D.E. Shaw & Co’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-407,352
| Closed | -$32.5M | – | 5172 |
|
|
2021
Q1 | $32.5M | Buy |
407,352
+177,026
| +77% | +$13.8M | 0.03% | 679 |
|
|
2020
Q4 | $18.2M | Buy |
230,326
+99,708
| +76% | +$5.85M | 0.02% | 1006 |
|
|
2020
Q3 | $5.74M | Sell |
130,618
-26,274
| -17% | -$1.29M | 0.01% | 1594 |
|
|
2020
Q2 | $6.94M | Buy |
156,892
+136,945
| +687% | +$5.11M | 0.01% | 1424 |
|
|
2020
Q1 | $716K | Buy |
+19,947
| New | +$1.13M | ﹤0.01% | 2990 |
|
|
2019
Q2 | – | Sell |
-7,001
| Closed | -$492K | – | 3971 |
|
|
2019
Q1 | $468K | Sell |
7,001
-41,586
| -86% | -$3.15M | ﹤0.01% | 3029 |
|
|
2018
Q4 | $3.62M | Sell |
48,587
-1,797
| -4% | -$148K | 0.01% | 1725 |
|
|
2018
Q3 | $4.64M | Sell |
50,384
-33,792
| -40% | -$3.22M | 0.01% | 1622 |
|
|
2018
Q2 | $8.28M | Buy |
+84,176
| New | +$9.41M | 0.01% | 1205 |
|
|
2017
Q3 | – | Sell |
-7,385
| Closed | -$575K | – | 3677 |
|
|
2017
Q2 | $575K | Buy |
+7,385
| New | +$555K | ﹤0.01% | 2740 |
|
|
2016
Q4 | – | Sell |
-8,246
| Closed | -$643K | – | 3677 |
|
|
2016
Q3 | $643K | Sell |
8,246
-4,495
| -35% | -$326K | ﹤0.01% | 2653 |
|
|
2016
Q2 | $876K | Buy |
+12,741
| New | +$879K | ﹤0.01% | 2491 |
|
D.E. Shaw & Co's CMD Position: Q2 2021 in Review
D.E. Shaw & Co sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 407,352 shares — an estimated $32.5M sold.
D.E. Shaw & Co first reported a position in CMD in Q2 2016 and held it in 12 quarters. The position peaked at $32.5M in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- D.E. Shaw & Co reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- D.E. Shaw & Co sold 407,352 Cantel Medical Corporation shares in Q2 2021, an estimated $32.5M.
- D.E. Shaw & Co first reported a position in Cantel Medical Corporation in Q2 2016 and held it in 12 quarters.
- D.E. Shaw & Co's Cantel Medical Corporation position peaked at $32.5M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on D.E. Shaw & Co's 13F filing for Q2 2021, filed 16 Aug 2021.